Abstract:Studies have suggested that dysregulation of peroxisomal lipid metabolism might play an important role in colorectal cancer (CRC) development. Here, we found that KrasG12D-driven CRC tumors demonstrate dysfunctional peroxisomal β-oxidation and identified Nudt7 (peroxisomal coenzyme A diphosphatase NUDT7) as one of responsible peroxisomal genes. In KrasG12D-driven CRC tumors, the expression level of Nudt7 was significantly decreased. Treatment of azoxymethane/dextran sulfate sodium (AOM/DSS) into Nudt7 knockout… Show more
“…NUDT7 and NUDT11 are both hydrolases that belong to the peroxisomal nudix family of enzymes ( 40 , 41 ). Mutations of NUDT7 have been described in colorectal cancer, inhibition of Nudt7 may contribute to the progression of Kras G12D colorectal cancer through upregulation of Wnt/β-catenin signaling and palmitic acid accumulation ( 42 ). Genetic and functional analyses showed that when NUDT11 was inhibited, colony formation of tumor-associated cell phenotypes was significantly reduced and their proliferation/survival capacity was compromised ( 43 ).…”
Gliomas are the most frequent primary malignant brain tumors of the central nervous system, causing significant impairment and death. There is mounting evidence that N7 methylguanosine (m7G) RNA dysmethylation plays a significant role in the development and progression of cancer. However, the expression patterns and function of the m7G RNA methylation regulator in gliomas are yet unknown. The goal of this study was to examine the expression patterns of 31 critical regulators linked with m7G RNA methylation and their prognostic significance in gliomas. To begin, we systematically analyzed patient clinical and prognostic data and mRNA gene expression data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. We found that 17 key regulators of m7G RNA methylation showed significantly higher expression levels in gliomas. We then divided the sample into two subgroups by consensus clustering. Cluster 2 had a poorer prognosis than cluster 1 and was associated with a higher histological grade. In addition, cluster 2 was significantly enriched for cancer-related pathways. Based on this discovery, we developed a risk model involving three m7G methylation regulators. Patients were divided into high-risk and low-risk groups based on risk scores. Overall survival (OS) was significantly lower in the high-risk group than in the low-risk group. Further analysis showed that the risk score was an independent prognostic factor for gliomas.
“…NUDT7 and NUDT11 are both hydrolases that belong to the peroxisomal nudix family of enzymes ( 40 , 41 ). Mutations of NUDT7 have been described in colorectal cancer, inhibition of Nudt7 may contribute to the progression of Kras G12D colorectal cancer through upregulation of Wnt/β-catenin signaling and palmitic acid accumulation ( 42 ). Genetic and functional analyses showed that when NUDT11 was inhibited, colony formation of tumor-associated cell phenotypes was significantly reduced and their proliferation/survival capacity was compromised ( 43 ).…”
Gliomas are the most frequent primary malignant brain tumors of the central nervous system, causing significant impairment and death. There is mounting evidence that N7 methylguanosine (m7G) RNA dysmethylation plays a significant role in the development and progression of cancer. However, the expression patterns and function of the m7G RNA methylation regulator in gliomas are yet unknown. The goal of this study was to examine the expression patterns of 31 critical regulators linked with m7G RNA methylation and their prognostic significance in gliomas. To begin, we systematically analyzed patient clinical and prognostic data and mRNA gene expression data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. We found that 17 key regulators of m7G RNA methylation showed significantly higher expression levels in gliomas. We then divided the sample into two subgroups by consensus clustering. Cluster 2 had a poorer prognosis than cluster 1 and was associated with a higher histological grade. In addition, cluster 2 was significantly enriched for cancer-related pathways. Based on this discovery, we developed a risk model involving three m7G methylation regulators. Patients were divided into high-risk and low-risk groups based on risk scores. Overall survival (OS) was significantly lower in the high-risk group than in the low-risk group. Further analysis showed that the risk score was an independent prognostic factor for gliomas.
“…In 2015 the gene expression analysis of 30 cancer cell lines identified NUDT4 as a potential target [ 61 ]. The combination and analysis of muti-omic data revealed NUDT7 as having a role in colorectal and breast cancer development [ 62 , 63 ].…”
Section: Exploiting Global Signaling and Omic Data To Discover Novmentioning
Despite global research efforts, breast cancer remains the leading cause of cancer death in women worldwide. The majority of these deaths are due to metastasis occurring years after the initial treatment of the primary tumor and occurs at a higher frequency in hormone receptor-positive (Estrogen and Progesterone; HR+) breast cancers. We have previously described the role of NUDT5 (Nudix-linked to moiety X-5) in HR+ breast cancer progression, specifically with regards to the growth of breast cancer stem cells (BCSCs). BCSCs are known to be the initiators of epithelial-to-mesenchyme transition (EMT), metastatic colonization, and growth. Therefore, a greater understanding of the proteins and signaling pathways involved in the metastatic process may open the door for therapeutic opportunities. In this review, we discuss the role of NUDT5 and other members of the NUDT family of enzymes in breast and other cancer types. We highlight the use of global omics data based on our recent phosphoproteomic analysis of progestin signaling pathways in breast cancer cells and how this experimental approach provides insight into novel crosstalk mechanisms for stratification and drug discovery projects aiming to treat patients with aggressive cancer.
“…Indeed, NUDT7 has been identified as a candidate susceptibility gene for familial CRC, with an early truncation, p.Y37X, found in two patients ( 109 ). Additionally, Nudt7 -/- mice treated with a combination of azoxymethane and dextran sulfate sodium develop more polyps and adenocarcinoma than WT mice ( 51 ). The changes in bile acid composition that stimulate the development of CRC have recently been linked to their effect on FXR activity ( 107 ), and deletion of Nudt7 affected FXR activity in a diet- and gender-specific manner ( Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Nudt7 -/- mice have been recently generated ( 50 , 51 ). These mice exhibit compromised cartilage integrity and the propensity to develop more colonic polyps, but the effect of Nudt7 deletion on (acyl-)CoA levels and global hepatic metabolism has yet to be characterized.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.